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Introduction
The autoimmune blistering skin diseases pemphigus vulgaris 
(PV) and pemphigus foliaceus (PF) are caused by autoanti-
bodies (IgG) against desmosomal cadherins and different anti-
gens, including cholinergic receptors (Hu et al., 1978; Amagai 
et al., 1991, 1995; Nguyen et al., 2000; Sitaru and Zillikens, 
2005). We have previously shown that PF-IgG caused cellular 
dissociation without directly inhibiting desmoglein (Dsg) 1 
binding when probed by laser tweezers and atomic force mi-
croscopy (Waschke et al., 2005a). These data favor the contribu-
tion of cellular signaling rather than a direct inhibitory action on 
Dsg binding.
To investigate signaling events in pemphigus blistering, 
we used an ex vivo human skin model (Schiltz and Michel, 
1976; Hu et al., 1978) and the human epidermal cell line  HaCaT. 
We focused on Rho GTPases in this study because they are 
  involved in the regulation of adhesion mediated by several 
members of the cadherin family (Fukata et al., 1999), and 
we found that the inhibition of Rho GTPases by Clostridium 
diffi  cile toxin B induced epidermal splitting similar to pemphi-
gus IgG (unpublished data). However, the role of Rho GTPases 
in the control of desmosomal adhesion is unclear at present 
(Braga and Yap, 2005). A previous study reported that Rho pro-
teins regulate epithelial cadherin (E-cadherin)–mediated adhe-
sion but not the maintenance of desmosomes in keratinocytes 
because the microinjection of C3 toxin to inhibit Rho A and a 
constitutively inactive mutant of Rac 1 altered the localization 
of E-cadherin but not of desmoplakin, a component of the des-
mosomal plaques (Braga et al., 1997). However, it is possible 
that the short incubation period of 25 min after microinjection 
used in the study was suffi  cient to destabilize adherens junc-
tions but not desmosomes. Thus, a defi  nitive conclusion con-
cerning the role of Rho GTPases in the regulation of desmosomal 
adhesion cannot be drawn from these studies. Our data demon-
strate for the fi  rst time that Rho A is involved in the maintenance 
of desmosomes and that interference with Rho A signaling con-
siderably contributes to pemphigus pathogenesis.
Results and discussion
Incubation of human skin for 24 h in the presence of PV- or PF-
IgG caused epidermal splitting, whereas no epidermal splitting 
was found after incubation in the absence of patients’ IgG or 
with IgG from a healthy volunteer (Fig. 1, A–C). PV-IgG1–
  induced splitting occurred suprabasally, whereas in the PF-IgG1–
treated epidermis, the cleavage plane was found to be both deep 
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T
he autoimmune blistering skin diseases pemphigus 
vulgaris (PV) and pemphigus foliaceus (PF) are 
mainly caused by autoantibodies against desmo-
somal cadherins. In this study, we provide evidence that 
PV–immunoglobulin G (IgG) and PF-IgG induce skin blis-
tering by interference with Rho A signaling. In vitro, pem-
phigus IgG caused typical hallmarks of pemphigus 
pathogenesis such as epidermal blistering in human 
skin, cell dissociation, and loss of desmoglein 1 (Dsg 1)–
  mediated binding probed by laser tweezers. These 
changes were accompanied by interference with Rho A 
activation and reduction of Rho A activity. Pemphigus 
IgG–triggered keratinocyte dissociation and Rho A inacti-
vation were p38 mitogen-activated protein kinase  dependent. 
Speciﬁ   c activation of Rho A by cytotoxic necrotizing 
  factor-y abolished all pemphigus-triggered effects, includ-
ing keratin retraction and release of Dsg 3 from the cyto-
skeleton. These data demonstrate that Rho A is involved in 
the regulation of desmosomal adhesion, at least in part by 
maintaining the cytoskeletal anchorage of desmosomal 
proteins. This may open the possibility of pemphigus treat-
ment with the epidermal application of Rho A agonists.
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(not depicted) and within the spinous layer (Fig. 1 A). In control 
skin, Dsg 3 was localized along cell junctions throughout the 
entire epidermis except for the granular layer, which displayed 
weak staining (Fig. 1 B, a). We used two different bacterial tox-
ins specifi  c for Rho family GTPases: Escherichia coli cytotoxic 
necrotizing factor 1 (CNF-1), a toxin that activates Rho A, Rac 1, 
and Cdc42 by deamidation (Schmidt et al., 1997, 1998), as 
well as CNFy from Yersinia pseudotuberculosis because it se-
lectively activates Rho A (Hoffmann et al., 2004). Selective ac-
tivation of Rho A by CNFy was equally effective as activation 
of Rho A, Rac 1, and Cdc42 by CNF-1 to block pemphigus 
IgG–induced skin splitting (Fig. 1, B and C). From these data, 
we concluded that Rho A is the primary Rho GTPase targeted 
by pemphigus IgG–triggered signaling mechanisms.
To further test this hypothesis, we performed parallel ex-
periments with cultured human keratinocytes (HaCaT) that, in 
contrast to the skin model, allow biophysical and biochemical 
studies. To detect pemphigus IgG–induced cell dissociation, we 
labeled the peripheral fi  lamentous actin (F-actin) ring in HaCaT 
monolayers by Alexa-phalloidin staining. F-actin was enriched 
in a beltlike marginal zone along cell junctions (Fig. 2 a). After 
24 h of incubation, PV-IgG1 (Fig. 2 b, arrows) as well as PF-
IgG1 (Fig. 2 e, arrows) caused intercellular gap formation ac-
companied by the reorganization of F-actin from cellular 
junctions to a cytoplasmic meshwork. CNFy completely abol-
ished pemphigus IgG–induced cell dissociation and actin reor-
ganization and increased stress fi  ber formation along junctions 
(Fig. 2; c, d, and f). Similar results were obtained using PV- and 
PF-IgG2 (unpublished data). We studied the effects of pemphi-
gus IgG on desmosome integrity by immunostaining for Dsg 3. 
In control cultures and monolayers incubated for 24 h in the 
presence of control IgG or CNFy, immunostaining for Dsg 3 re-
mained localized to cell junctions (Fig. 3 A, a–c). Under the 
same conditions, PV-IgG2 and PF-IgG1 induced profound al-
terations of Dsg 3 immunolocalization (Fig. 3 A, e and i). In ex-
periments using PF-IgG1, Dsg 3 staining remained continuously 
localized to cell junctions in areas where no gaps were present 
and was abolished at gap margins only (Fig. 3 A, i; arrows). 
Overall, changes induced by PV-IgG were stronger compared 
with effects induced by PF-IgG and ranged from the complete 
disappearance of Dsg 3 staining in some areas of the monolayer to 
substantial fragmentation of the continuous junction-associated 
Dsg 3 immunostaining (Fig. 3 A, e). Similar results were 
  obtained using PV-IgG1 and PF-IgG2 (unpublished data).
Cell dissociation was observed with all patients’ IgG frac-
tions as well as after the inhibition of Rho A by a cell-permeable 
C3 fusion toxin for 24 h (Fig. 3 A, d). The latter fi  nding is in con-
trast to an earlier study from Braga et al. (1997). In this study, 
Figure 1.  Effect of Rho A activation on pemphigus IgG–
  induced epidermal splitting. (A, a) Hematoxylin and eosin 
staining of human skin reveals no epidermal splitting in the 
absence of pemphigus IgG. (b and c) PV- and PF-IgG1–
  induced epidermal splitting after 24 h of incubation. Bar, 
250 μm. (B, a) Dsg 3 is localized along cell junctions in hu-
man epidermis. (b–e) Epidermal splitting caused by PV-IgG1 
and 2 (arrows; b and d) is inhibited by simultaneous CNFy-
mediated activation of Rho GTPases. (f) Control IgG had no 
effect. (g–j) Splitting caused by PF-IgG1 and 2 (arrows; g and i) 
was also abrogated by CNFy. Bar, 50 μm. (C) PV-IgG1– and 
2– as well as PF-IgG1– and 2–induced epidermal splitting 
(measured as the split length in micrometers relative to the 
length of the section in millimeters) was abolished by CNF-1 
as well as by CNFy (the number of sections are as follows: 
111 control, 28 control IgG, 50 PV-IgG1, 51 PV-IgG2, 24 
PV-IgG1 + CNF-1, 26 PV-IgG1 + CNFy, 31 PV-IgG2 + CNF-1, 
31 PV-IgG2 + CNFy, 37 PF-IgG1, 63 PF-IgG2, 35 PF-IgG1 + 
CNF-1, 32 PF-IgG1 + CNFy, 24 PF-IgG2 + CNF-1, and 
30 PF-IgG2 + CNFy). Error bars represent SEM.RHO IN PEMPHIGUS SKIN BLISTERING • WASCHKE ET AL. 723
the microinjection of C3 toxin to inhibit Rho A was found 
to displace E-cadherin from intercellular junctions in human 
  keratinocytes, whereas the distribution of desmoplakin was not 
affected. From this result, it was concluded that Rho GTPases 
are not involved in the regulation of desmosomal adhesion. As 
outlined above, the failure of Rho A inhibition might be caused 
by the technical design of the study. When incubation with PV- 
and PF-IgG was performed in the presence of CNFy to selec-
tively activate Rho A or with CNF-1, cellular dissociation and 
alteration of Dsg 3 staining in monolayers treated with PV-IgG2 
(Fig. 3 A, f and g) or PF-IgG1 (Fig. 3 A, j and k) were almost 
completely abrogated. Similarly, the simultaneous inhibition of 
p38 MAPK by SB 202190 (Fig. 3 A, h and l) but not the inhibi-
tion of PKC by chelerythrine (not depicted) inhibited effects of 
PV-IgG2 and PF-IgG1, supporting recent fi  ndings from Berkowitz 
et al. (2005, 2006) both in vivo and in vitro. Collectively, these 
results indicate that autoantibody-induced keratinocyte dissoci-
ation in situ and in vitro as well as the loss of desmosomes in 
vitro can be suppressed by the activation of Rho A. Moreover, 
together with the observation that specifi  c inhibition of Rho A 
by C3 fusion toxin also induced keratinocyte dissociation and 
the loss of desmosomes, these data demonstrate for the fi  rst 
time that the GTPase Rho A is critically involved in the mainte-
nance of desmosomes.
Next, we tested the effect of pemphigus IgG and Rho 
A activation on the localization of desmoplakin and E-cadherin 
as well as on the keratin fi  lament cytoskeleton. Compared with 
controls (Fig. 3 B, a–c), PV-IgG1 induced strong alterations of 
desmoplakin localization paralleled by keratin retraction, 
whereas the effects on the localization of E-cadherin and plako-
globin (not depicted) were less severe (Fig. 3 B, d–f; arrows 
pointing to the sides of cell dissociation). This is in line with 
previous studies describing desmoplakin fragmentation and 
keratin retraction (Caldelari et al., 2001; Calkins et al., 2006). 
However, when Rho A was activated by CNFy in the presence 
of PV-IgG1, the staining of desmoplakin and E-cadherin along 
Figure 3.  Effects of pemphigus IgG and Rho A activation on the localiza-
tion of desmosomal proteins, cytokeratin 14, and E-cadherin. (A) HaCaT 
cells were stained for Dsg 3. (a–c) Continuous distribution of Dsg 3 along 
cell junctions in keratinocytes was not affected by control IgG or CNFy. 
(d) C3 fusion toxin caused cell dissociation and the loss of desmosomes. 
(e–h) The loss of Dsg 3 staining induced by PV-IgG2 (e) was blocked by ei-
ther CNF-1 (f), CNFy (g), or SB 202190 (h). (i–l) Similarly, PF-IgG1–
  triggered intercellular gap formation (arrows; i) was inhibited by CNF-1 (j), 
CNFy (k), and SB 202190 (l). n = 5. Bar, 50 μm. (B) HaCaT monolayers 
were stained for desmoplakin (a, d, and g), cytokeratin 14 (b, e, and h), 
and E-cadherin (c, f, and i). (a–c) In controls, desmoplakin and E-cadherin 
were localized at cell junctions, whereas cytokeratin 14 displayed a cyto-
plasmic meshwork. (d–f) PV-IgG1 induced cell dissociation, with the loss of 
desmoplakin and E-cadherin staining (arrows) accompanied by keratin re-
traction. (g–i) Rho A activation by CNFy abolished cell dissociation and 
keratin retraction and largely reduced desmoplakin fragmentation (arrows). 
Under these conditions, cytokeratin 14 formed dense bundles perpendicu-
lar to cell junctions (arrowheads). (C) The effect of Rho kinase inhibition by 
Y27632 on the CNFy-mediated inhibition of PV-IgG1 was investigated 
by double staining for desmoplakin (a) and F-actin (b). (B and C) n = 5. 
Bars, 20 μm.
Figure 2.  Pemphigus-IgG–induced keratinocyte dissociation in HaCaT 
monolayers. Alexa-phalloidin staining of actin ﬁ  laments (F-actin) was used 
to sensitively detect cell dissociation. (a and b) Compared with controls, PV-
IgG1 (24 h) caused cell dissociation (arrows) and profound alterations of 
F-actin distribution. (c) Cell dissociation was abolished by CNFy. (d) CNFy 
increased stress ﬁ  bers along cell borders. (e and f) PF-IgG1–triggered cell 
dissociation (arrows; e) was inhibited by CNFy (f). n = 5. Bar, 35 μm.JCB • VOLUME 175 • NUMBER 5 • 2006  724
cell junctions was enhanced compared with controls (Fig. 3 B, 
g and j), and the fragmentation of desmoplakin was only rarely 
observed (Fig. 3 B, g; arrow). Under these conditions, keratin 
retraction was abolished, and many cells displayed dense kera-
tin fi  lament bundles running perpendicular to cell junctions 
(Fig. 3 B, h; arrowheads). Similar results were obtained using 
PV-IgG2 and PF-IgG1/2 (not depicted).
Inhibition of Rho kinase by Y27632 in addition to treat-
ment with PV-IgG1 and CNFy partially blocked the protective 
effect of Rho activation on desmoplakin localization (Fig. 3 C, 
a and c), whereas the CNFy-induced inhibition of cell dissocia-
tion was not affected (Fig. 3 C, b and c), suggesting that Rho 
  kinase is involved in some of the mechanisms regulated by Rho A. 
In summary, these data indicate that Rho A activation abrogates 
the pemphigus IgG–mediated disruption of desmosome anchor-
age to the keratin fi  lament cytoskeleton.
On the basis of these results, we conclude that the activa-
tion of Rho A is suffi  cient to abrogate central events involved in 
Figure 4.  Effect of pemphigus IgG on Rho A activity and 
  activation. Rho A activation assays were performed after incu-
bation with PV- and PF-IgG1. Therefore, HaCaT cell lysates 
(indicating the total amount of the respective GTPase) and the 
pull-down fraction (indicating the active amount of the 
GTPase) were subjected to SDS-PAGE followed by Western 
blotting. The total content of Rho A was similar under all con-
ditions. (A and B) PV- and PF-IgG1 reduced the activity of Rho 
A to  50%. (C and D) Activation of Rho A by CNF-1 was re-
duced in the presence of pemphigus IgG. (E and F) SB 
202190 inhibited Rho A inactivation by pemphigus IgG. 
(G and H) Besides Rho A, CNF-1 activated Rac 1 and Cdc42, 
whereas CNFy selectively activated Rho A. Note that as a re-
sult of the variable sensitivity of the activation assays, the ac-
tivity of Rho A, Rac 1, and Cdc42 could not be determined 
under control conditions in all experiments (C, G, and H). The 
experiments shown are representative of three performed. 
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pemphigus blistering, like keratinocyte dissociation and epider-
mal splitting. To determine whether pemphigus IgG reduced the 
activity of Rho A in cultured HaCaT cells, we assayed Rho A ac-
tivity by the ability of the GTPase to bind to the specifi  c effector 
protein rhotekin coupled to agarose beads (Fig. 4). After incuba-
tion for 120 min, both PV- and PF-IgG1 reduced the amount of 
active Rho A to  50% of control levels (n = 3; Fig. 4, A and B). 
Comparable results were obtained using PV- and PF-IgG2 (un-
published data). Next, we investigated whether the activation of 
Rho A was modifi  ed in response to pemphigus IgG because con-
stant activation is required for Rho proteins to cycle between ac-
tive and inactive states. When CNF-1 was applied together with 
PV- and PF-IgG1 for 120 min, the ability of CNF-1 to cause the 
activation of Rho A was decreased to 30 and 36% (n = 3) com-
pared with cells treated with CNF-1 alone (Fig. 4, C and D).
Because the inhibition of p38 MAPK was equally effi  cient 
as Rho A activation to block pemphigus IgG–triggered keratino-
cyte dissociation, we investigated whether p38 MAPK was in-
volved in Rho A inactivation in response to pemphigus IgG. 
When HaCaT monolayers were incubated with PV- and PF-
IgG1 in the presence of the p38 MAPK inhibitor SB 202190, the 
IgG-triggered inactivation of Rho A was abolished (Fig. 4, E 
and F), indicating that p38 MAPK is part of the signaling cas-
cade leading to Rho A inactivation. Finally, we proved that 
CNF-1 activated all three Rho proteins in human keratinocytes 
(i.e., Rho A [Fig. 4, A and B], Rac 1, and Cdc42 [Fig. 5 G]), 
whereas CNFy selectively activated Rho A (Fig. 4 H). Collec-
tively, the results indicate that pemphigus IgG causes the inhibi-
tion of Rho A in a p38 MAPK–dependent manner, presumably 
by interference with GTPase activation.
We further characterized the mechanisms underlying 
Rho A–mediated maintenance of desmosomes and used the laser 
tweezer technique as a functional assay to study Dsg 1–mediated 
adhesion. In this assay, microbeads coated with recombinant 
Dsg 1 are allowed to settle on the surface of HaCaT cells for 
30 min, where many beads undergo formation of desmosome-like 
cell to bead contacts as described previously (Waschke et al., 
2005a). During this time course, typically  65% of Dsg 1–coated 
beads had formed tight adhesive contacts and could no longer 
be displaced by the laser beam (Fig. 5 A). These control values 
were set to 100%. Adhesion of Dsg 1–coated beads was not sig-
nifi  cantly changed by incubation with control IgG for 120 min, 
whereas incubation with CNF-1 or CNFy increased the number of 
bound beads to 118 ± 5 and 122 ± 6%, respectively (P < 0.05). 
However, both the inhibition of Rho A by C3 fusion toxin 
(180 min) and the inhibition of Rho kinase by Y27632 for 
180 min resulted in a signifi  cant reduction of bound beads 
to 52 ± 5 and 58 ± 4% of controls, respectively (P < 0.05). 
PV-IgG1 and 2 (120 min) also reduced bead binding to 82 ± 7 and 
52 ± 5% of control levels. PV-IgG1– and 2–induced reduction of 
Dsg 1 binding was completely inhibited by simultaneous treat-
ment of cultures with either CNF-1 or CNFy. Similarly, both 
CNF-1 and CNFy completely inhibited the weakening of bead 
binding caused by PF-IgG1 and 2. Thus, these experiments 
support our fi  ndings on cell dissociation in that the activation 
of Rho A alone is suffi  cient to prevent autoantibody-triggered 
weakening of Dsg 1–mediated adhesion. Because the specifi  c 
inhibition of Rho A by C3 fusion toxin and the inhibition of Rho 
kinase also reduced Dsg 1 binding, we conclude that Rho A and 
Rho kinase are required for strong Dsg 1–mediated adhesion.
Our fi  ndings indicate that Rho A regulates the anchorage 
of desmosomes to the keratin fi  lament cytoskeleton, which is 
required for strong Dsg 1 binding and maintenance of desmosomes. 
To test the cytoskeletal anchorage of desmosomal proteins, 
triton extraction can be used (Caldelari et al., 2001). Both 
PV- and PF-IgG1 increased Dsg 3 in the triton-soluble fraction 
of cell lysates, indicating that the anchorage of Dsg 3 to the cyto-
skeleton is reduced by pemphigus IgG (Fig. 5 B). Activation 
of Rho A by CNFy reversed the effects of PV- and PF-IgG1. 
Collectively, these data are consistent with our aforementioned 
results that the activation of Rho A blocked pemphigus IgG–
  induced keratin retraction and fragmentation of Dsg 3 and des-
moplakin. Dsg 3 levels were not substantially decreased in the 
cytoskeletal fractions after 24 h of incubation with pemphigus 
IgG. This was similarly observed using higher concentrations 
(1 mg/ml) of patients’ IgG (unpublished data). However, a 
  recent study showed that Dsg 3 was substantially reduced after 
incubation with PV-IgG (Calkins et al., 2006), indicating that 
the mechanisms underlying pemphigus skin blistering are rather 
Figure 5.  Effect of Rho A activation on the pemphigus IgG–induced loss of 
Dsg 1–mediated binding and on the reduction of the cytoskeletal anchor-
age of Dsg 3. (A) Dsg 1–coated microbeads were allowed to settle on the 
surface of HaCaT cells for 30 min and afterward were subjected to a laser 
beam. Beads not displaced by the laser beam were considered bound and 
set to 100% (controls). When added afterward, incubation with C3 fusion 
toxin or Y27632 reduced bead adhesion. PV-IgG1 and 2, PF-IgG1 and 2, 
or control IgG were applied alone or in the presence of CNF-1 or CNFy. 
PV- and PF-IgG signiﬁ  cantly reduced the number of bound Dsg 1–coated 
beads, whereas control IgG had no effect (P < 0.05). However, the CNF-1–
induced activation of Rho GTPases increased bead adhesion when ap-
plied alone and abrogated the reduction of Dsg 1 binding caused by 
pemphigus IgG. Speciﬁ  c activation of Rho A by CNFy was equally effec-
tive (n = 6 for each condition). (B) Cytoskeletal anchorage of Dsg 3 was 
assessed by Western blotting of the soluble and corresponding cytoskeletal 
fraction after incubation with pemphigus IgG in the absence or presence of 
CNFy. The experiments shown are representative of three performed. Error 
bars represent SEM.JCB • VOLUME 175 • NUMBER 5 • 2006  726
complex and do not seem to be the same in different patients at 
all stages of the disease.
Collectively, we provide evidence that Rho A is critically 
involved in pemphigus pathogenesis and in the maintenance of 
desmosomes. However, at present, it is not clear how the inacti-
vation of Rho proteins is induced by antibody binding. It is pos-
sible that signaling pathways caused by autoantibodies inhibit 
dissociation of the negative regulator Rho guanine nucleotide 
dissociation inhibitor from Rho A, thereby preventing GTP 
loading and making it ineffective to bind to its effector mole-
cules. We found that the inactivation of Rho A was dependent 
on p38 MAPK, which is in line with a recent study (Berkowitz 
et al., 2005). Plakoglobin and PKC may also be involved in 
pemphigus pathogenesis (Seishima et al., 1999; Caldelari et al., 
2001; Sanchez-Carpintero et al., 2004). Moreover, the precise 
mechanisms by which Rho A regulates desmosomal adhesion 
remain to be elucidated. We demonstrate that Rho A regulates 
the anchorage of desmosomal proteins to the keratin fi  lament 
cytoskeleton. Finally, Rho A and Rho kinase seem to be re-
quired to provide strong Dsg 1 binding. Because Rho A activa-
tion inhibits the blistering effects of pemphigus IgG in human 
epidermis, this might be used as a new therapeutic approach 
with the possibility of topical epidermal application. Future 
studies are required to test whether Rho A activation by differ-
ent approaches is effective in vivo.
Materials and methods
Cell culture and test reagents
HaCaT cells were cultured as described previously and were used for all 
experiments when grown to conﬂ  uent monolayers (Waschke et al., 2005a). 
CNF-1 and CNFy were prepared and characterized as described previ-
ously (Schmidt et al., 1997, 1998; Hoffmann et al., 2004). Preliminary 
experiments indicated that CNF-1 at a dose of 300 ng/ml for 120 min and 
CNFy at a dose of 600 ng/ml for 6 h were necessary to induce the activa-
tion of Rho proteins (Waschke et al., 2006). For experiments using human 
epidermis, 1,200 ng/ml of both toxins were required. The cell-permeable 
C3 fusion toxin was a gift from H. Barth (University of Ulm, Ulm, Germany) 
and was used at 300 ng/ml for 180 min. Y27632 (Calbiochem) was used 
at 30 μM, and p38 MAPK inhibitor SB 202190 (Calbiochem) was   applied 
at 10 μM. The speciﬁ  c inhibitor of PKC, chelerythrine (Sigma-Aldrich), was 
used at 10 μM.
Puriﬁ  cation of PF-IgG
Sera from two PF patients and two patients suffering from a mucocutaneous 
form of PV whose diagnosis was conﬁ  rmed clinically, histologically, and 
serologically and from a volunteer without any skin disease (control) were 
used for this study. Patients’ sera were tested by ELISA for reactivity against 
Dsg 1 and 3, respectively. All sera contained Dsg 1 antibodies, whereas 
Dsg 3 antibodies were only present in PV-IgG fractions. Puriﬁ  cation was 
performed as described previously (Waschke et al., 2005a). Concentra-
tions of all IgG fractions were adjusted to a 150-μg/ml ﬁ  nal concentration 
for all experiments.
Ex vivo model of human skin splitting
The model is similar to the technique established previously (Schiltz and 
Michel, 1976; Hu et al., 1978). Skin pieces were taken from fresh cadav-
ers of individuals not suffering from any skin disease who had donated 
their bodies to the Institute of Anatomy and Cell Biology of Würzburg. Via-
bility of the epidermis after incubation in DME at 37°C in the absence and 
presence of PV-IgG was conﬁ  rmed by incubation with 3-[4,5-dimethylthia-
zol-2-yl]-2,5-diphenyl-tetrazolim bromide (MTT; Sigma-Aldrich) for 30 min, 
which was converted to a colored formazan by mitochondrial dehydroge-
nases using heat-inactivated epidermis (65°C for 30 min) as a negative 
control (Cole, 1986). Specimens were incubated with DME containing 
10% FCS and 1.8 mM Ca
2+ for 24 h in the presence or absence of PV- or 
PF-IgG alone or in combination with 1,200 ng/ml CNF-1 or CNFy. After 
brief rinsing with PBS (consisting of 137 mM NaCl, 2.7 mM KCl, 8.1 mM 
Na2HPO4, and 1.5 mM KH2PO4, pH 7.4), skin specimens were mounted 
on copper plates using Reichert-Jung mounting medium (Cambridge Instru-
ments) and frozen in liquid nitrogen. 5-μm–thick cryosections were ob-
tained using a cryostat (Reichert-Jung 2800 Frigocut; Cambridge 
Instruments). Cryosections were stained with hematoxylin and eosin for his-
tomorphological evaluation. For each condition, three to ﬁ  ve pieces of skin 
(2 × 2 mm) from at least two different cadavers were used and incubated 
in the presence or absence of patients’ IgG separately. From three to ﬁ  ve 
skin pieces, 24–111 different sections were evaluated under the various 
conditions (numbers of sections evaluated for each condition are given in 
the ﬁ  gure legends). After each section harvested, at least 50 μm of tissue 
were discarded. In the next section, it was veriﬁ  ed by microscopic evalua-
tion that no epidermal splitting was found to ensure that each blister mea-
sured was counted not more than once. For each blister, the total split 
length was measured and normalized to the length of the speciﬁ  c section 
given in millimeters.
Cytochemistry
After incubation with autoantibodies, immunostaining was performed as 
described previously (Waschke et al., 2005a). After ﬁ  xation with ice-cold 
acetone for 2 min and incubation with normal goat serum and 1% BSA at 
RT, monolayers were incubated for 16 h at 4°C with mouse monoclonal 
antibody directed to Dsg 3 (Zytomed), rabbit polyclonal to desmoplakin 
(Biozol), mouse monoclonal to cytokeratin 14 (Chemicon), or mouse mono-
clonal to E-cadherin (BD Transduction Laboratories; each dilution was 
1:100 in PBS). After several rinses with PBS (three times for 5 min each), 
monolayers were incubated for 60 min at RT with Cy3-labeled secondary 
antibodies (Dianova). For the visualization of F-actin, Alexa-phalloidin 
  (Invitrogen) diluted 1:60 in PBS was used (incubation for 1 h at RT). Cells 
incubated with antibodies or Alexa-phalloidin were rinsed with PBS 
(three times for 5 min each).
Laser tweezer
The expression and puriﬁ   cation of recombinant Dsg 1, coating of poly-
styrene beads, and the laser tweezer setup were described previously 
(Waschke et al., 2005a). Throughout all experiments, the laser intensity was 
42 mW in the focal plane. Coated beads (10 μl of stock solution) were 
  suspended in 200 μl of culture medium and allowed to interact with HaCaT 
monolayers for 30 min at 37°C before measuring the number of bound 
beads (equal to control values). Beads were considered tightly bound when 
resisting laser displacement at a 42-mW setting. For every condition, 100 
beads were counted. Afterward, control IgG, PV-IgG, or PF-IgG were ap-
plied under various conditions for 120 min, and the number of bound beads 
was counted again. The percentage of beads resisting laser displacement 
under various experimental conditions was normalized to control values.
Rho protein activation assay
To test the effect of pemphigus IgG on the activation of Rho proteins, 
  HaCaT cells were treated with either PF-IgG, PV-IgG, CNF-1, CNFy, or SB 
202190 alone or in combinations as indicated before cells were subjected 
to activation assay kits for Rho A (Upstate Biotechnology), which were ap-
plied according to the manufacturer’s instructions. The technique was used 
as described previously (Waschke et al., 2006).
Protein extraction
Extraction, Western blotting, and immunodetection were essentially per-
formed as described previously (Waschke et al., 2005b) with the following 
exceptions. HaCaT cells were grown to full conﬂ  uence in six-well dishes. 
After incubation with pemphigus IgG in the absence or presence of CNFy, 
monolayers were incubated with extraction buffer (1% Triton X-100, 
10 mM Tris, 140 mM NaCl, 5 mM EDTA, and 2 mM EGTA) containing 
protease inhibitor solution (20 μg/ml each of leupetin, pepstatin, and 
aprotinin and 1 mM PMSF; all were obtained from Sigma-Aldrich) for 10 min 
on ice. Cells were scraped, vortexed brieﬂ  y, and centrifuged at 14,000 g 
for 30 min. The supernatant was collected and deﬁ  ned as the Triton-soluble 
fraction. The pellet was deﬁ  ned as the cytoskeletal fraction and dissolved 
immediately in 10% SDS-containing sample buffer at 95°C for 5 min. 
Finally, immunodetection was performed using mouse monoclonal Dsg 3 
antibody (Zytomed) diluted 1: 1,000 in PBS.
Image acquisition and manipulation
The histology and immunoﬂ   uorescent images were taken with a micro-
scope (LSM 510; Carl Zeiss MicroImaging, Inc.) using 40× NA 1.3 
oil plan Neoﬂ   uar and 63× NA 1.4 oil plan Apochromat objectives RHO IN PEMPHIGUS SKIN BLISTERING • WASCHKE ET AL. 727
(Carl Zeiss MicroImaging, Inc.). Images were taken by RT in antifade as an 
imaging medium for immunoﬂ  uorescence and 80% glycerol for hematoxy-
lin and eosin staining. The ﬂ  uorochromes used were Cy3 and Alexa488. 
Densitometric quantiﬁ  cation of Western blot bands was performed using 
Photoshop 7.0 software (Adobe). Photoshop 7.0 software was also used 
for the adjustment of contrast and brightness.
Statistics
Differences in bead adhesion and epidermal splitting were assessed using the 
t test. In text and bar diagrams, values were expressed as the mean ± SEM. 
Statistical signiﬁ  cance was assumed for P < 0.05.
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